##4071313
A	a	zz1
57-year-old	57-year-old	jj
male	male	jj_nn1
singer	singer	nn1
with	with	iw
noninsulin-dependent	noninsulin-dependent	jj_nn1@
(	(	y
type	type	nn1
2	2	mc
)	)	y
diabetes	diabetes	nn1
mellitus	mellitus	nn1
and	and	cc
primary	primary	jj_nn1
hyperparathyroidism	hyperparathyroidism	nn1
presented	present	vvn_vvd
with	with	iw
a	a	at1
complaint	complaint	nn1
of	of	io
diplacusis	diplacusis	nn1
in	in	ii
the	the	at
right	right	jj_nn1
ear	ear	nn1
of	of	io
16	16	mc
months	month	nnt2
'	'	ge
duration	duration	nn1
.	.	y
The	the	at
diplacusis	diplacusis	nn1
was	be	vbdz
accompanied	accompany	vvn
by	by	ii
tinnitus	tinnitus	nn1_jj
,	,	y
aural	aural	jj
fullness	fullness	nn1
,	,	y
and	and	cc
hyperacusis	hyperacusis	nn1
in	in	ii
the	the	at
same	same	da
ear	ear	nn1
:	:	y
<>		null
"	"	y
The	the	at
patient	patient	nn1
described	describe	vvd_vvn
the	the	at
diplacusis	diplacusis	nn1
as	as	ii
a	a	at1
harmonic	harmonic	nn1@_jj
of	of	io
a	a	at1
fundamental	fundamental	jj
sound	sound	nn1
in	in	ii31
response	response	ii32
to	to	ii33
external	external	jj
sound	sound	nn1
and	and	cc
to	to	ii
his	his	appge
own	own	da
voice	voice	nn1
.	.	y
When	when	cs
the	the	at
diplacusis	diplacusis	nn1
was	be	vbdz
most	most	rgt
severe	severe	jj
,	,	y
he	he	pphs1
would	would	vm
also	also	rr
hear	hear	vvi
a	a	at1
third	third	md
sound	sound	nn1
,	,	y
either	either	rr
in	in	ii31
response	response	ii32
to	to	ii33
an	a	at1
external	external	jj
sound	sound	nn1
or	or	cc
as	as	ii_csa
a	a	at1
spontaneous	spontaneous	jj
sound	sound	nn1
that	that	cst_dd1
was	be	vbdz
close	close	jj
to	to	ii
the	the	at
quality	quality	nn1
of	of	io
his	his	appge
tinnitus	tinnitus	nn1_jj
.	.	y
<>		null
"	"	y
The	the	at
tinnitus	tinnitus	nn1
seemed	seem	vvd
to	to	to
be	be	vbi
triggered	trigger	vvn
by	by	ii
the	the	at
intake	intake	nn1
of	of	io
dairy	dairy	nn1
and	and	cc
salicylate	salicylate	vv0_nn1
products	product	nn2
,	,	y
and	and	cc
it	it	pph1
could	could	vm
be	be	vbi
controlled	control	vvn
to	to	ii
some	some	dd
degree	degree	nn1
by	by	ii
avoidance	avoidance	nn1
of	of	io
these	these	dd2
substances	substance	nn2
.	.	y
Another	another	dd1
type	type	nn1
of	of	io
"	"	y
howling	howling	jj_vvg
"	"	y
tinnitus	tinnitus	nn1
arose	arise	vvd
either	either	rr
spontaneously	spontaneously	rr
or	or	cc
in	in	ii31
association	association	ii32
with	with	ii33
the	the	at
intake	intake	nn1
of	of	io
these	these	dd2
products	product	nn2
.	.	y
<>		null
"	"	y
The	the	at
aural	aural	jj
fullness	fullness	nn1
was	be	vbdz
intermittent	intermittent	jj
,	,	y
although	although	cs
it	it	pph1
appeared	appear	vvd
to	to	to
be	be	vbi
related	relate	vvn
to	to	ii
the	the	at
intake	intake	nn1
of	of	io
dairy	dairy	nn1
products	product	nn2
and	and	cc
salt	salt	nn1
.	.	y
<>		null
"	"	y
The	the	at
hyperacusis	hyperacusis	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
<>		null
Four	four	mc
months	month	nnt2
after	after	ii_cs
the	the	at
onset	onset	nn1
of	of	io
these	these	dd2
symptoms	symptom	nn2
,	,	y
the	the	at
patient	patient	nn1
had	have	vhd
experienced	experience	vvn
a	a	at1
1-week	1-week	jj_nnt1
period	period	nn1
of	of	io
recurrent	recurrent	jj
mild	mild	jj
positional	positional	jj
rotary	rotary	jj_nn1
vertigo	vertigo	nn1
.	.	y
Each	each	dd1
episode	episode	nn1
lasted	last	vvd_vvn@
for	for	if
approximately	approximately	rr
90	90	mc
seconds	second	nnt2
.	.	y
His	his	appge
family	family	nn1
history	history	nn1
included	include	vvd_vvn
a	a	at1
sister	sister	nn1
who	who	pnqs
had	have	vhd
undergone	undergo	vvn
stapedectomy	stapedectomy	nn1
.	.	y
He	he	pphs1
was	be	vbdz
taking	take	vvg
metformin	metformin	nn1
for	for	if
the	the	at
diabetes	diabetes	nn1
.	.	y
<>		null
The	the	at
patient	patient	nn1
said	say	vvd
that	that	cst
the	the	at
diplacusis	diplacusis	nn1
was	be	vbdz
very	very	rg
distracting	distracting	jj@_vvg
during	during	ii
his	his	appge
daily	daily	jj
activities	activity	nn2
,	,	y
although	although	cs
he	he	pphs1
had	have	vhd
been	be	vbn
able	able	jk
to	to	to
overcome	overcome	vvi
the	the	at
response	response	nn1
from	from	ii
his	his	appge
own	own	da
voice	voice	nn1
by	by	ii
altering	alter	vvg
his	his	appge
vocal	vocal	jj
technique	technique	nn1
.	.	y
He	he	pphs1
had	have	vhd
been	be	vbn
previously	previously	rr
treated	treat	vvn
with	with	iw
three	three	mc
intratympanic	intratympanic	jj
corticosteroids	corticosteroid	nn2
,	,	y
but	but	ccb
he	he	pphs1
felt	feel	vvd
that	that	cst
this	this	dd1
treatment	treatment	nn1
might	might	vm
have	have	vhi
only	only	rr
made	make	vvn
his	his	appge
symptoms	symptom	nn2
worse	bad	jjr_rrr@
.	.	y
He	he	pphs1
had	have	vhd
also	also	rr
been	be	vbn
treated	treat	vvn
with	with	iw
oral	oral	jj
prednisone	prednisone	nn1
,	,	y
betahistine	betahistine	nn1_jj
,	,	y
diuretics	diuretics	nn2_nn1
,	,	y
and	and	cc
liothyronine	liothyronine	nn1_jj
without	without	iw
benefit	benefit	nn1
.	.	y
<>		null
The	the	at
patient	patient	nn1
had	have	vhd
brought	bring	vvn
with	with	iw
him	him	ppho1
the	the	at
results	result	nn2
of	of	io
serial	serial	jj
audiometric	audiometric	jj
tests	test	nn2
that	that	cst
had	have	vhd
showed	show	vvn
a	a	at1
fluctuating	fluctuating	jj
low-frequency	low-frequency	jj
hearing	hearing	nn1
loss	loss	nn1
in	in	ii
the	the	at
right	right	jj_nn1
ear	ear	nn1
,	,	y
although	although	cs
one	one	mc1
of	of	io
these	these	dd2
tests	test	nn2
showed	show	vvd
that	that	cst
the	the	at
right	right	jj_nn1
ear	ear	nn1
was	be	vbdz
normal	normal	jj
.	.	y
He	he	pphs1
himself	himself	ppx1
had	have	vhd
not	not	xx
noticed	notice	vvn
any	any	dd
hearing	hearing	nn1
loss	loss	nn1
.	.	y
Findings	finding	nn2
on	on	ii
previous	previous	jj
magnetic	magnetic	jj
resonance	resonance	nn1
imaging	image	vvg_nn1
with	with	iw
enhancement	enhancement	nn1
had	have	vhd
been	be	vbn
negative	negative	jj
for	for	if
any	any	dd
abnormality	abnormality	nn1
,	,	y
and	and	cc
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
level	level	nn1
.	.	y
<>		null
At	at	ii
the	the	at
patient	patient	nn1
'	'	ge
s	s	zz1
first	first	md
visit	visit	nn1_vv0
to	to	ii
the	the	at
author	author	nn1
'	'	ge
s	s	zz1
office	office	nn1
,	,	y
neurotologic	neurotologic	jj
testing	testing	nn1
with	with	iw
tuning	tune	vvg
forks	fork	nn2
revealed	reveal	vvd_vvn
diplacusis	diplacusis	nn1
at	at	ii
512	512	mc
,	,	y
2	2	mc
,	,	y
048	048	mc
,	,	y
and	and	cc
4	4	mc
,	,	y
096	096	mc
Hz	hz	nnu
.	.	y
The	the	at
patient	patient	nn1
said	say	vvd
the	the	at
sound	sound	nn1
from	from	ii
the	the	at
512-		nn1_jj
and	and	cc
2	2	mc
,	,	y
048-Hz		jj_nnu
tuning	tuning	nn1@_vvg
forks	fork	nn2
was	be	vbdz
louder	loud	jjr
in	in	ii
the	the	at
right	right	jj_nn1
ear	ear	nn1
than	than	csn
in	in	ii
the	the	at
left	left	jj_nn1@
.	.	y
He	he	pphs1
experienced	experience	vvd
significantly	significantly	rr
more	more	dar
difficulty	difficulty	nn1
performing	perform	vvg
the	the	at
sharpened	sharpened	jj
tandem	tandem	nn1
Romberg	romberg	np1
test	test	nn1_vv0
with	with	iw
the	the	at
right	right	jj_nn1
foot	foot	nn1
forward	forward	rl
than	than	csn
with	with	iw
the	the	at
left	left	jj
foot	foot	nn1
forward	forward	rl
.	.	y
<>		null
At	at	ii
the	the	at
second	second	md
visit	visit	nn1
,	,	y
audiometry	audiometry	nn1
showed	show	vvd
pure	pure	jj
tones	tone	nn2
at	at	ii
45	45	mc
dB	db	nnu
at	at	ii
250	250	mc
and	and	cc
500	500	mc
Hz	hz	nnu
,	,	y
with	with	iw
both	both	db2
ears	ear	nn2
equal	equal	jj_vv0%
from	from	ii
1.	1	mc
0	0	mc
kHz	khz	nnu
and	and	cc
higher	high	jjr_rrr@
.	.	y
High-frequency	high-frequency	jj_nn1
hearing	hearing	nn1
testing	testing	nn1_vvg
revealed	reveal	vvd_vvn_jj@
hearing	hear	vvg_nn1
in	in	ii
both	both	db2
ears	ear	nn2
to	to	ii
15	15	mc
kHz	khz	nnu
.	.	y
The	the	at
tinnitus	tinnitus	nn1_jj
in	in	ii
the	the	at
right	right	jj_nn1
ear	ear	nn1
could	could	vm
not	not	xx
be	be	vbi
matched	match	vvn
.	.	y
The	the	at
speech-reception	speech-reception	jj_nn1
threshold	threshold	nn1
was	be	vbdz
20	20	mc
dB	db	nnu
in	in	ii
the	the	at
right	right	jj_nn1
ear	ear	nn1
and	and	cc
10	10	mc
dB	db	nnu
in	in	ii
the	the	at
left	left	jj_nn1@
.	.	y
Speech	speech	nn1
discrimination	discrimination	nn1
in	in	ii
quiet	quiet	jj_nn1@
and	and	cc
in	in	ii
simulated	simulated	jj
background	background	nn1
noise	noise	nn1
was	be	vbdz
normal	normal	jj
in	in	ii
both	both	db2
ears	ear	nn2
,	,	y
although	although	cs
it	it	pph1
was	be	vbdz
slightly	slightly	rr
less	less	rrr_dar
in	in	ii
the	the	at
right	right	nn1_jj
.	.	y
Otoacoustic	otoacoustic	jj
emissions	emission	nn2
,	,	y
both	both	rr_db2
transient	transient	jj
evoked	evoke	vvn_vvd
and	and	cc
distortion	distortion	nn1
product	product	nn1
,	,	y
were	be	vbdr
present	present	jj_nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
Thin-section	thin-section	jj_nn1
direct	direct	jj
axial	axial	jj
computed	computed	jj@
tomography	tomography	nn1
(	(	y
CT	ct	np1@_nn1
)	)	y
of	of	io
the	the	at
right	right	jj_nn1
temporal	temporal	jj
bone	bone	nn1
revealed	reveal	vvd_vvn
a	a	at1
large	large	jj
sclerotic	sclerotic	jj
plaque	plaque	nn1
from	from	ii
the	the	at
base	base	nn1
at	at	ii
the	the	at
footplate	footplate	nn1
level	level	nn1
to	to	ii
the	the	at
apex	apex	nn1
,	,	y
a	a	at1
moderate	moderate	jj
to	to	ii
large	large	jj
sclerotic	sclerotic	jj
plaque	plaque	nn1
of	of	io
the	the	at
anterior	anterior	jj
oval	oval	jj_nn1
window	window	nn1
,	,	y
and	and	cc
a	a	at1
moderately	moderately	rr
thickened	thicken	vvn_vvd
spongiotic	spongiotic	jj
footplate	footplate	nn1
,	,	y
which	which	ddq
the	the	at
radiologist	radiologist	nn1
interpreted	interpret	vvn_vvd
as	as	csa_ii@
otosclerosis	otosclerosis	nn1
of	of	io
the	the	at
right	right	jj_nn1
ear	ear	nn1
.	.	y
On	on	ii
the	the	at
left	left	jj
side	side	nn1
,	,	y
CT	ct	np1@_nn1
revealed	reveal	vvd
a	a	at1
small	small	jj
sclerotic	sclerotic	jj
plaque	plaque	nn1
at	at	ii
the	the	at
base	base	nn1
of	of	io
the	the	at
temporal	temporal	jj
bone	bone	nn1
at	at	ii
the	the	at
footplate	footplate	nn1
level	level	nn1
and	and	cc
some	some	dd
spotty	spotty	jj
demineralization	demineralization	nn1
posterior	posterior	nn1
to	to	ii
the	the	at
apex	apex	nn1
.	.	y
<>		null
A	a	at1_zz1
2-hour	2-hour	jj
glucose	glucose	nn1
tolerance	tolerance	nn1
test	test	nn1
showed	show	vvd
diabetic	diabetic	jj
levels	level	nn2
of	of	io
blood	blood	nn1
glucose	glucose	nn1
and	and	cc
slightly	slightly	rr
elevated	elevated	jj_vvn
levels	level	nn2
of	of	io
insulin	insulin	nn1
.	.	y
Thus	thus	rr
,	,	y
the	the	at
patient	patient	nn1
was	be	vbdz
placed	place	vvn
on	on	ii
a	a	at1
strict	strict	jj
diabetic	diabetic	jj_nn1
diet	diet	nn1
,	,	y
and	and	cc
the	the	at
metformin	metformin	nn1
was	be	vbdz
continued	continue	vvn
.	.	y
He	he	pphs1
was	be	vbdz
also	also	rr
started	start	vvn
on	on	ii
risedronate	risedronate	nn1_jj
30	30	mc
mg	mg	nnu
twice	twice	rr
weekly	weekly	jj_rr@
along	along	ii21
with	with	ii22
calcium	calcium	nn1
,	,	y
vitamin	vitamin	nn1
D	d	zz1
,	,	y
and	and	cc
sodium	sodium	nn1
monofluorophosphate	monofluorophosphate	nn1
to	to	to
address	address	vvi
the	the	at
otosclerosis	otosclerosis	nn1
.	.	y
<>		null
At	at	ii
follow-up	follow-up	nn1_jj
3	3	mc
months	month	nnt2
later	later	rrr
,	,	y
the	the	at
patient	patient	nn1
reported	report	vvd_vvn
that	that	cst
the	the	at
diplacusis	diplacusis	nn1
had	have	vhd
become	become	vvn@
a	a	rr21
little	little	rr22
worse	bad	jjr_rrr@
,	,	y
the	the	at
aural	aural	jj
fullness	fullness	nn1
more	more	rgr
pervasive	pervasive	jj
,	,	y
and	and	cc
the	the	at
hyperacusis	hyperacusis	nn1
worse	bad	rrr@_jjr
on	on	ii
the	the	at
days	day	nnt2
he	he	pphs1
took	take	vvd
the	the	at
risedronate	risedronate	nn1_jj
.	.	y
Repeat	repeat	vv0
audiometry	audiometry	nn1
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
placed	place	vvn
on	on	ii
an	a	at1
alternating	alternating	jj
regimen	regimen	nn1
of	of	io
etidronate	etidronate	nn1_jj
400	400	mc
mg/day	mg/day	fu
for	for	if
2	2	mc
weeks	week	nnt2
and	and	cc
risedronate	risedronate	vv0_nn1_jj
30	30	mc
mg	mg	nnu
twice	twice	rr
weekly	weekly	jj
for	for	if
4	4	mc
weeks	week	nnt2
.	.	y
<>		null
The	the	at
patient	patient	nn1
returned	return	vvn_vvd
in	in	ii
another	another	dd1
3	3	mc
months	month	nnt2
and	and	cc
reported	report	vvn
that	that	cst
the	the	at
diplacusis	diplacusis	nn1
was	be	vbdz
better	better	jjr
toward	toward	ii
the	the	at
end	end	nn1
of	of	io
the	the	at
etidronate	etidronate	jj_nn1
cycle	cycle	nn1
but	but	ccb
worse	bad	rrr@_jjr
on	on	ii
days	day	nnt2
when	when	rrq
he	he	pphs1
took	take	vvd
risedronate	risedronate	nn1_jj
.	.	y
The	the	at
diplacusis	diplacusis	nn1
had	have	vhd
become	become	vvn@
better	better	rrr
in	in	ii
that	that	dd1
fewer	fewer	dar
pitches	pitch	nn2
were	be	vbdr
affected	affect	vvn
.	.	y
Overall	overall	rr_nn1
,	,	y
the	the	at
tinnitus	tinnitus	nn1_jj
and	and	cc
the	the	at
aural	aural	jj
fullness	fullness	nn1
were	be	vbdr
better	better	rrr_jjr
than	than	csn
they	they	pphs2
had	have	vhd
been	be	vbn
at	at	ii
the	the	at
previous	previous	jj
visit	visit	nn1
,	,	y
although	although	cs
he	he	pphs1
did	do	vdd
feel	feel	vvi
pressure	pressure	nn1
in	in	ii
the	the	at
right	right	jj_nn1
ear	ear	nn1
when	when	cs_rrq
he	he	pphs1
did	do	vdd
not	not	xx
follow	follow	vvi
his	his	appge
diet	diet	nn1
.	.	y
The	the	at
hyperacusis	hyperacusis	nn1
was	be	vbdz
unchanged	unchanged	jj
,	,	y
and	and	cc
the	the	at
results	result	nn2
of	of	io
hearing	hear	vvg_nn1
tests	test	nn2
were	be	vbdr
unchanged	unchanged	jj
.	.	y
The	the	at
alternating	alternating	jj
bisphosphonate	bisphosphonate	jj_nn1
regimen	regimen	nn1
was	be	vbdz
changed	change	vvn
to	to	to
etidronate	etidronate	vvi
400	400	mc
mg/day	mg/day	fu
for	for	if
2	2	mc
weeks	week	nnt2
and	and	cc
risedronate	risedronate	vv0_nn1_jj
30	30	mc
mg	mg	nnu
twice	twice	rr
weekly	weekly	jj
for	for	if
6	6	mc
weeks	week	nnt2
.	.	y
<>		null
Four	four	mc
months	month	nnt2
later	later	rrr
,	,	y
no	no	at
change	change	nn1
had	have	vhd
occurred	occur	vvn
in	in	ii
the	the	at
diplacusis	diplacusis	nn1
;	;	y
it	it	pph1
remained	remain	vvd
better	better	rrr_jjr
toward	toward	ii
the	the	at
end	end	nn1
of	of	io
the	the	at
etidronate	etidronate	jj_nn1
cycle	cycle	nn1
and	and	cc
worse	bad	jjr_rrr@
during	during	ii
the	the	at
days	day	nnt2
on	on	ii
risedronate	risedronate	nn1_jj
.	.	y
On	on	ii
a	a	at1
comparative	comparative	jj
listening	listening	jj_nn1
test	test	nn1
with	with	iw
a	a	at1
dial	dial	nn1
tone	tone	nn1
,	,	y
there	there	ex
was	be	vbdz
less	less	dar_rrr
distortion	distortion	nn1
in	in	ii
the	the	at
right	right	jj_nn1
ear	ear	nn1
.	.	y
The	the	at
tinnitus	tinnitus	nn1
remained	remain	vvd_vvn
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
remained	remain	vvd_vvn
present	present	nn1_jj
,	,	y
but	but	ccb
the	the	at
patient	patient	nn1
was	be	vbdz
able	able	jk
to	to	to
ignore	ignore	vvi
it	it	pph1
.	.	y
The	the	at
hyperacusis	hyperacusis	nn1
was	be	vbdz
less	less	rgr
frequent	frequent	jj
and	and	cc
less	less	rgr
acute	acute	jj
.	.	y
There	there	ex
were	be	vbdr
no	no	at
significant	significant	jj
changes	change	nn2
in	in	ii
the	the	at
results	result	nn2
of	of	io
hearing	hear	vvg_nn1
tests	test	nn2
.	.	y
The	the	at
patient	patient	nn1
offered	offer	vvd_vvn
that	that	cst
he	he	pphs1
found	find	vvd
the	the	at
diabetes	diabetes	nn1
diet	diet	nn1
to	to	to
be	be	vbi
"	"	y
draconian	draconian	jj
.	.	y
"	"	y
The	the	at
alternating	alternating	jj
bisphosphonate	bisphosphonate	jj_nn1
regimen	regimen	nn1
was	be	vbdz
changed	change	vvn
to	to	to
etidronate	etidronate	vvi
400	400	mc
mg/day	mg/day	fu
for	for	if
2	2	mc
weeks	week	nnt2
and	and	cc
risedronate	risedronate	vv0_nn1_jj
30	30	mc
mg	mg	nnu
twice	twice	rr
weekly	weekly	jj
for	for	if
11	11	mc
weeks	week	nnt2
.	.	y
<>		null
Six	six	mc
months	month	nnt2
later	later	rrr
,	,	y
which	which	ddq
marked	mark	vvd@
the	the	at
16th	16th	md
month	month	nnt1
of	of	io
treatment	treatment	nn1
overall	overall	nn1_rr
,	,	y
the	the	at
patient	patient	nn1
returned	return	vvn_vvd
(	(	y
and	and	cc
brought	bring	vvn_vvd
with	with	iw
him	him	ppho1
an	a	at1
article	article	nn1
on	on	ii
monaural	monaural	jj_nn1
diplacusis	diplacusis	nn1
(	(	y
n1	n1	fo
)	)	y
)	)	y
.	.	y
Since	since	cs
his	his	appge
previous	previous	jj
visit	visit	nn1
,	,	y
the	the	at
diplacusis	diplacusis	nn1
was	be	vbdz
much	much	rr
improved	improve	vvn_jj_vvd
;	;	y
in	in	ii
fact	fact	nn1
,	,	y
it	it	pph1
had	have	vhd
almost	almost	rr
disappeared	disappear	vvn
and	and	cc
was	be	vbdz
no	no	rr21
longer	long	rr22
a	a	at1
distraction	distraction	nn1
.	.	y
The	the	at
tinnitus	tinnitus	nn1_jj
and	and	cc
aural	aural	jj
fullness	fullness	nn1
were	be	vbdr
the	the	at
same	same	da
as	as	csa
they	they	pphs2
had	have	vhd
been	be	vbn
at	at	ii
the	the	at
previous	previous	jj
visit	visit	nn1
,	,	y
but	but	ccb
the	the	at
hyperacusis	hyperacusis	nn1
was	be	vbdz
almost	almost	rr
gone	go	vvn
.	.	y
The	the	at
results	result	nn2
of	of	io
repeat	repeat	vv0_nn1%
hearing	hear	vvg_nn1
tests	test	nn2
remained	remain	vvd
the	the	at
same	same	da
with	with	iw
the	the	at
exception	exception	nn1
of	of	io
improved	improved	jj
findings	finding	nn2
with	with	ii31
respect	respect	ii32
to	to	ii33
the	the	at
transient	transient	jj
evoked	evoke	vvd_vvn
otoacoustic	otoacoustic	jj
emissions	emission	nn2
(	(	y
figure	figure	nn1
)	)	y
.	.	y
Compared	compare	vvn
with	with	iw
the	the	at
previous	previous	jj
visit	visit	nn1
,	,	y
the	the	at
patient	patient	nn1
'	'	ge
s	s	zz1
hearing	hearing	nn1
was	be	vbdz
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
Hz	hz	nnu
.	.	y
This	this	dd1
is	be	vbz
a	a	at1
case	case	nn1
of	of	io
monaural	monaural	jj_nn1
diplacusis.		nnu
n2	n2	fo
Based	base	vvn
on	on	ii
the	the	at
patient	patient	nn1
'	'	ge
s	s	zz1
response	response	nn1
to	to	ii
treatment	treatment	nn1
,	,	y
the	the	at
etiology	etiology	nn1
appears	appear	vvz
to	to	to
be	be	vbi
otosclerosis	otosclerosis	nn1
and	and	cc
type	type	nn1
2	2	mc
diabetes	diabetes	nn1
with	with	iw
elevated	elevated	jj
insulin	insulin	nn1
levels	level	nn2
.	.	y
The	the	at
intratympanic	intratympanic	jj
corticosteroids	corticosteroid	nn2
might	might	vm
have	have	vhi
produced	produce	vvn
a	a	at1
permanent	permanent	jj
hearing	hearing	nn1
loss	loss	nn1
as	as	ii
a	a	at1
result	result	nn1
of	of	io
their	their	appge
effect	effect	nn1
on	on	ii
osteoprotegerin	osteoprotegerin	nn1
in	in	ii
the	the	at
inner	inner	jj
ear.	ear	nnu
(	(	y
n3	n3	fo
,	,	y
n4	n4	fo
)	)	y
<>		null
Figure	figure	nn1
.	.	y
Graphs	graph	nn2
show	show	vv0
the	the	at
transient	transient	jj
evoked	evoke	vvd_vvn
otoacoustic	otoacoustic	jj
emissions	emission	nn2
before	before	ii_cs
treatment	treatment	nn1
(	(	y
A	a	zz1
)	)	y
and	and	cc
after	after	ii_cs
16	16	mc
months	month	nnt2
of	of	io
treatment	treatment	nn1
(	(	y
B	b	zz1
)	)	y
.	.	y
<>		null
L	l	zz1_np1@
:	:	y
References	reference	nn2
(	(	y
n1	n1	fo
.	.	y
)	)	y
Ward	ward	np1
W.	w	np1
Tonal	tonal	jj
monaural	monaural	jj_nn1
diplacusis	diplacusis	nn1
.	.	y
J	xx_j	np1@_zz1
Acoust		np1
Soc	soc	np1
Am	am	ra@
1955	1955	mc
;	;	y
27	27	mc
:	:	y
365-72.		mcmc
<>		null
(	(	y
n2	n2	fo
.	.	y
)	)	y
Knight	knight	np1
RD	rd	nnl1
.	.	y
Diplacusis	diplacusis	nn1_np1@
,	,	y
hearing	hear	vvg_nn1
threshold	threshold	nn1
and	and	cc
otoacoustic	otoacoustic	jj
emissions	emission	nn2
in	in	ii
an	a	at1
episode	episode	nn1
of	of	io
sudden	sudden	jj
,	,	y
unilateral	unilateral	jj
cochlear	cochlear	jj
hearing	hearing	nn1
loss	loss	nn1
.	.	y
Int	int	zz_j
J	xx_j	zz1_np1@
Audiol	audiol	np1_vv0_nn1
2004	2004	mc
;	;	y
43(1)	43(1)	fo
:	:	y
45-53.	45-53	mcmc
<>		null
(	(	y
n3	n3	fo
.	.	y
)	)	y
Zehnder	zehnder	np1
AF	af	np1
,	,	y
Kristiansen	kristiansen	np1
AG	ag	fo
,	,	y
Adams	adams	np1
JC	jc	np1
,	,	y
et	et	ra21
al	al	ra22
.	.	y
Osteoprotegerin	osteoprotegerin	nn1_np1@
in	in	ii
the	the	at
inner	inner	jj
ear	ear	nn1
may	may	vm
inhibit	inhibit	vvi
bone	bone	nn1
remodeling	remodel	vvg
in	in	ii
the	the	at
otic	otic	jj
capsule	capsule	nn1
.	.	y
Laryngoscope	laryngoscope	nn1_np1@
2005	2005	mc
;	;	y
115(1)	115(1)	fo
:	:	y
172-7.		mcmc
<>		null
(	(	y
n4	n4	fo
.	.	y
)	)	y
Brookler	brookler	np1@
K.	k	np1
Basis	basis	nn1
for	for	if
understanding	understand	vvg
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
@		ii
:	:	y
160-1	160-1	mcmc
.	.	y
<>		null
By	by	ii
Kenneth	kenneth	np1
H.	h	np1
Brookler	brookler	np1
,	,	y
MD	md	nna
,	,	y
MS	ms	nn1
,	,	y
FRCSC	frcsc	np1
,	,	y
From	from	ii
Neurotologic	neurotologic	jj
Associates	associate	nn2
,	,	y
PC	pc	nn1
,	,	y
New	new	np1
York	york	np1
City.	city	np1
<>		null
